Autocoro最新技术: e-save

能源成本上涨速度高于纱线价格上涨速度,Autocoro纺纱厂每年的能耗成本约占每年营业额的5％,主要能耗是电能.     

电源效率冲上电力市场浪尖？

政府机构正在与公用事业公司合作,减少由于低效率电源所导致的功耗增长。在今天的电力供应市场上,效率是一个热门话题。增加效率曾是一个被忽视的角色,但现在却是一个全球性的重要动向。这种转变有两个主要原因。     

Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial

OBJECTIVE: We examined the effects of aprotinin on graft patency, prevalence of myocardial infarction, and blood loss in patients undergoing primary coronary surgery with cardiopulmonary bypass. METHODS: Patients from 13 international sites were randomized to receive intraoperative aprotinin (n = 436) or placebo (n = 434). Graft angiography was obtained a mean of 10.8 days after the operation. Electrocardiograms, cardiac enzymes, and blood loss and replacement were evaluated. RESULTS: In 796 assessable patients, aprotinin reduced thoracic drainage volume by 43% (P < .0001) and requirement for red blood cell administration by 49% (P < .0001). Among 703 patients with assessable saphenous vein grafts, occlusions occurred in 15.4% of aprotinin-treated patients and 10.9% of patients receiving placebo (P = .03). After we had adjusted for risk factors associated with vein graft occlusion, the aprotinin versus placebo risk ratio decreased from 1.7 to 1.05 (90% confidence interval, 0.6 to 1.8). These factors included female gender, lack of prior aspirin therapy, small and poor distal vessel quality, and possibly use of aprotinin-treated blood as excised vein perfusate. At United States sites, patients had characteristics more favorable for graft patency, and occlusions occurred in 9.4% of the aprotinin group and 9.5% of the placebo group (P = .72). At Danish and Israeli sites, where patients had more adverse characteristics, occlusions occurred in 23.0% of aprotinin- and 12.4% of placebo-treated patients (P = .01). Aprotinin did not affect the occurrence of myocardial infarction (aprotinin: 2.9%; placebo: 3.8%) or mortality (aprotinin: 1.4%; placebo: 1.6%). CONCLUSIONS: In this study, the probability of early vein graft occlusion was increased by aprotinin, but this outcome was promoted by multiple risk factors for graft occlusion.     

Objective functional assessment of total hip arthroplasty following two common surgical approaches: the posterior and direct lateral approaches

Despite the high number of total hip arthroplasty (THA) procedures performed each year, there is no common consensus on the best surgical approach. Gait is known to improve following THA although it does not return to what is typically quantified as normal, and surgical approach is believed to be a contributing factor. The current study evaluates postoperative hip function and provides an objective assessment following two common surgical approaches: the McFarland-Osborne direct lateral and the southern posterior. Faced with the common problem of providing an objective comparison from the wealth of data collected using motion analysis techniques, the current study investigates the application of an objective classification tool to provide information on the effectiveness of each surgery and to differentiate between the characteristics of hip function following the two approaches. Seven inputs for the classifier were determined through statistical analysis of the biomechanical data. The posterior approach group exhibited greater characteristics of non-pathological gait and displayed a greater range of functional ability as compared with the lateral approach cohort. The classification tool has proved to be successful in characterizing non-pathological and THA function but was insufficient in distinguishing between the two surgical cohorts.     

Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis

BACKGROUND: To identify predictors of long-term outcome after balloon aortic valvuloplasty, we analyzed data on 674 adults (mean age, 78 +/- 9 years; 56% were women) undergoing this procedure at 24 clinical centers who had a mean initial increase in aortic valve area of 0.3 cm2. METHODS AND RESULTS: Baseline data included clinical, echocardiographic, and catheterization variables. Follow-up data included mortality, cause of death, rehospitalization, 6-month echocardiography, and functional status. Kaplan-Meier curves and log-rank tests were used to evaluate survival in subgroups. Multivariate Cox regression models were used to identify independent predictors of survival. Overall survival was 55% at 1 year, 35% at 2 years, and 23% at 3 years, with the majority of deaths (70%) classified as cardiac by an independent review committee. Rehospitalization was common (64%), although 61% of survivors at 2 years reported improved symptoms. Echocardiography at 6 months (n = 115) showed restenosis from the postprocedural valve area of 0.78 +/- 0.31 cm2 to 0.65 +/- 0.25 cm2 (P < .0001). With stepwise multivariate analysis, sequentially adding clinical, echocardiographic, and catheterization variables, the overall model identified independent predictors of survival as baseline functional status, baseline cardiac output, renal function, cachexia, female gender, left ventricular systolic function, and mitral regurgitation. Baseline and postprocedural variables were examined to identify which subgroup of patients has the best outcome after aortic valvuloplasty. A "lower-risk" subgroup (28% of the study population), defined by normal left ventricular systolic function and mild clinical functional limitation, had a 3-year survival of 36% compared with 17% in the remainder of the study group. CONCLUSIONS: Long-term survival after balloon aortic valvuloplasty is poor with 1- and 3-year survival rates of 55% and 23%, respectively. Although survivors report fewer symptoms, early restenosis and recurrent hospitalization are common.     

胰腺癌经动脉灌注化疗指南（草案）

【摘要】 胰腺癌是恶性度最高的实体肿瘤之一。对不能手术切除的胰腺癌，经动脉灌注化疗由于肿瘤局部药物浓度较静脉用药高，可以达到更好的治疗效果，在改善疾病相关症状、延长生存期、减少肝转移及发生肝转移后的治疗上均取得了令人瞩目的成绩。本文在相关概念、禁忌证、适应证、术前准备、操作方法、术后处理及并发症的预防和处理等方面给出了较详尽的规范化建议，旨在帮助国内同行作出合理决策，但不是强制性标准，也不可能包括和解决胰腺癌经动脉灌注化疗中的所有问题。因此，在面对某一患者时，应在充分了解本病的最佳医学证据，结合患者具体病情及其意愿的基础上，为患者制定合理的诊疗计划。
     

孤立性肠系膜上动脉夹层介入治疗五例的护理体会

【摘要】 目的 探讨裸支架腔内血管重建术治疗孤立性肠系膜上动脉夹层（ＳＭＡＤ）的围手术期护理。方法 对采用裸支架载瘤动脉腔内血管重建术治疗孤立性的５例患者，予完善的术前准备，针对性的术后观察、护理。结果 在围手术期精心护理下，４例腹痛症状患者术后３周腹痛消失；５例患者介入治疗均获得成功，术后无并发症发生，随访３至１２个月效果满意。结论 术前充分准备，术后细致观察、护理，为孤立性ＳＭＡＤ介入治疗提供有价值的护理经验。
     

综合性放射防护措施在介入治疗防护中的应用

【摘要】 目的 探讨综合性放射防护措施在介入治疗防护中的应用价值。方法 在８４例介入手术治疗中联合应用床下铅橡胶帘、铅玻璃防护屏、铅防护服、铅围脖、铅眼镜及距离等对介入操作人员进行综合性防护。利用ＦＪ?鄄２０００个人剂量仪监测Ｘ射线辐射剂量，并对相关数据进行统计分析。结果 床下铅橡胶帘防护效率为９３．４％；铅玻璃防护屏防护效率为９３．５％；铅防护服防护效率为８８．４％；这些放射防护器材前后Ｘ线辐射剂量差异均具有统计学意义（Ｐ ＜ ０．０１）。距球管１ ｍ处 Ｘ线衰减量为５８．６％，距球管３ ｍ处的Ｘ线衰减量为８６．４％。１ ｍ与２ ｍ之间，２ ｍ与３ ｍ之间的辐射剂量差异均具有统计学意义（Ｐ ＜ ０．０１）。结论 综合性防护措施在介入操作中可有效降低Ｘ射线辐射、减少对介入操作人员身体危害。
     

锁骨下动脉闭塞机械再通的方法研究

目的研究锁骨下动脉闭塞血管内机械再通方法和疗效。方法选择３２例症状性锁骨下动脉闭塞患者行血管内机械再通治疗，观察再通率及疗效。结果３２例锁骨下动脉闭塞患者中，用不同方法成功完成血管内机械再通后行血管内支架成形术，术后全部患者后循环缺血症状和上肢缺血症状明显改善。结论采用适当方法行机械再通治疗锁骨下动脉闭塞安全、可行。     

应用覆膜支架介入救治颈动脉破裂并假性动脉瘤

目的探讨应用覆膜支架介入治疗颈动脉破裂并假性动脉瘤.方法4例肿瘤所致颈动脉破裂并假性动脉瘤形成的患者,均出现颈部或口腔危及生命的出血,采用Seldinger方法,选用自膨式聚四氟乙烯覆膜支架治疗.结果4例成功施行血管内介入治疗,其中颈总动脉中段1例,颈动脉球2例,颈总动脉远段1例.共置入覆膜支架6枚.术后假性动脉瘤腔被隔绝,颈动脉通畅,患者的临床症状明显改善,无神经功能障碍.1例患者11 d后支架下缘颈总动脉与原瘤腔相通,再次置入覆膜支架,2个月的随访无再出血.1例患者经钢圈栓塞、放置覆膜支架及裸支架瘤腔